InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,061.72
(
1.24%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rocketeer357

Send PM Follow Ignore
Followers 32
Posts 3548
Boards Moderated 0
Alias Born 07/02/2004

rocketeer357

Re: north40000 post# 87586

Sunday, 04/26/2015 8:06:35 AM

Sunday, April 26, 2015 8:06:35 AM

Post# of 97239

IMO, STEM doesn't contend or compete with NVIV in any way.

STEM is a bounce play for me. To date, stem cell treatments haven't panned out in late stage trials (ATHX stage 2 recently for one) Given that STEM has no treatments in phase 3 as of yet, the hope is that they can actually show cause for phase 3 trials to happen sometime in the future...but that's a long way down the road.


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up